[Appleton D.J.. Rand J.S., S u n v o 1 d G.D. (2001). Insulin sensitivity decreases with obesity', and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. J. Feline Med. Surg., 3: 211-288.]Search in Google Scholar
[Butler AE., Janson J.. Bonner-Weir S., Ritzel R, Rizza RA, Butler P.C. (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 52: 102-110.]Search in Google Scholar
[Callegari C., Mercuriali E., Hafner M, Coppola L.M., Guazzetti S., Lutz T.A., R e u s c h C.E.. Z i n i E. (2013). Survival time and prognostic factors in cats with newly diagnosed diabetes mellitus: 114 cases (2000-2009). J. Am. Vet. Med. Assoc., 243: 91-95.]Search in Google Scholar
[Caney S.M (2013). Pancreatitis and diabetes in cats. Vet. Clin. North. Am. Small. Anim Pract.. 43: 303-317.]Search in Google Scholar
[Colditz G. A, Willett W.C., RotnitzkyA,Manson J.E. (1995). Weight gain as a risk factor for clinical diabetes in women. Ann. Intern. Med.. 122: 481-486.]Search in Google Scholar
[Crenshaw' KL.. Peterson M.E. (1996). Pretreatment clinical and laboratory evaluation of cats with diabetes mellitus: 104 cases (1992-1994). J. Am. Vet. Med. Assoc., 209: 943-949.]Search in Google Scholar
[Davidson J. A (2013). The placement of DPP 4 inhibitors in clinical practice recommendations for the treatment of type 2 diabetes. Endocr. Pract.. 19: 1050-1061.]Search in Google Scholar
[Donath MY., Gross D.J., Cerasi E., Kaiser N. (1999). Hvperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammonas obesus during development of diabetes. Diabetes. 48: 738-744.]Search in Google Scholar
[Donath MY.,Ehses J.A.,Maedler K,Schumann D.M,Ellingsgaard H.,Eppler E., Reinecke M. (2005). Mechanisms of beta-cell death in type 2 diabetes. Diabetes. 54: S108-S113.]Search in Google Scholar
[Drucker D.J. (2006). The biology of incretin homiones. Cell. Metab.. 3: 153-165.]Search in Google Scholar
[Drucker D.J., N a u c k MA. (2006). The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 368: 1696-1705.]Search in Google Scholar
[Ellingsgaard H., Hauselmann I., Schuler B., Habib A.M., Baggio LI., Meier D.T., Eppler E., Bouzakri K, Wueest S., Muller Y.D., Hansen A.M, Reinecke M,Konrad D.,Gassmann M,Reimann F.,Halban P.A,Gromada J.,Druck- e r D.J., Gribbe F.M., Ehses J.A, Donath MY. (2011) Interleukin-6 enhances insulin se- cretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat. Med.. 17: 1481-489.]Search in Google Scholar
[Ezcurra M., Reimann F., Gribble F.M, Emery E. (2013). Molecular mechanisms of incretin hormone secretion. Curr. Opin. Pharmacol.. 13: 922-927.]Search in Google Scholar
[Furrer D.. Kaufmann K. Tschuor F., Reusch C.E., Lutz TA. (2010). The dipeptidyl peptidase IV inhibitor NVP-DPP728 reduces plasma glucagon concentration in cats. Vet. J.. 183: 355-357.]Search in Google Scholar
[Gilor C.,Graves TK,Gilor S.,Ridge TK,Rick M(2011 a).TheGLP-l mimeticexenatide potentiates insulin secretion in healthy cats. Domest. Anim Endocrinol., 41: 42-49. 10.1016/j.domaniend.2011.03.00121645806]Search in Google Scholar
[Gilor C., Graves T.K. Gilor S.. Ridge T.K, Weng RY., Dos sin O. (2011 b). The incretin effect in cats: comparison between oral glucose, lipids, and amino acids. Domest. Anim. Endo- crinol., 40:205-212.10.1016/j.domaniend.2011.01.00221397435]Search in Google Scholar
[Goossens M.M., Nelson RW.. Feldman E.C., Griffey S.M. (1998). Responses to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995). J. Vet. Intern. Med.. 12: 1-6.]Search in Google Scholar
[Greco D.S. (2012). Feline acromegaly. Top. Companion Anim Med.. 27: 31-35.]Search in Google Scholar
[Hall D.G., Kelley L.C., Gray M.L., Glaus T.M (1997). Lymphocytic inflammation of pancre- atic islets in a diabetic cat. J. Vet. Diagn Invest., 9: 98-100.]Search in Google Scholar
[Henson M.S.. O'Brien TD. (2006). Feline models of type 2 diabetes mellitus. ILAR J., 47: 234-242.]Search in Google Scholar
[Hoen g M (2012). The cat as a model for human obesity and diabetes. J. Diabetes. Sei. TechnoL. 6: 525-533.]Search in Google Scholar
[Hoenig M, Thomaseth K. Brandao J., Waldron M, Ferguson D.C. (2006). Assess- ment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domest. Anim Endocrin.. 31: 373-389.]Search in Google Scholar
[Hoenig M, Thomaseth K, Waldron M, Ferguson D.C. (2007). Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am. J. Physiol. Regul. Integr. Comp. Physiol., 292: R227-2634.]Search in Google Scholar
[Hoenig M., Jordan E.T., Fergus on D.C., de Vries F. (2010). Oral glucose leads to a differ- ential response in glucose, insulin, and GLP-1 in lean versus obese cats. Domest. Anim. Endocrin.. 38: 95-102.]Search in Google Scholar
[Hotamisligil G.S., Arner P., Caro J.F., Atkinson RL., Spiegelman B.M (1995). In- creased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resis- tance. J. Clin. Invest., 95: 2409-2415.]Search in Google Scholar
[Imamura S.,Hirai K.Hirai A. (2013). The glucagon-like peptide-1 receptor agonist, liraglutide. attenuates the progression of overt diabetic nephropathy in type 2 diabetic patients. Tohoku J. Exp. Med., 231: 57-61.]Search in Google Scholar
[Inzucchi S.E., S h e r w i n RS. (2005). The prevention of type 2 diabetes mellitus. Endocrinol. Me- tab. Clin. North. Am., 34: 199-219.]Search in Google Scholar
[Johnson K.H.. Hayden D.W., O'Brien T.D., Westermark P. (1986). Animal model of hu- man disease: spontaneous diabetes mellitus-islet amyloid complex in adult cats. Am. J. Pathol.. 125: 416-419.]Search in Google Scholar
[Johnson KH., O 'Brien T.D., Jordan K, Westermark P. (1989). Impaired glucose toler- ance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. Am J. Pathol., 135: 245-250.]Search in Google Scholar
[Kirby M.,Yu DM., O ’ Connor S.,Gorrel M.D. (2010). Inhibitor selectivity in the clinical ap- plication of dipeptidyl peptidase-4 inhibition. Clin. Sei., 118: 31-41.]Search in Google Scholar
[Kraus M.S., C a 1 v e r t C. A, Jacobs G.J., B r o w n J. (1997). Feline diabetes mellitus: a retrospec- tive mortality study of 55 cats (1982-1994). J. Am. Anim. Hosp. Assoc., 33: 107-111.]Search in Google Scholar
[Lederer R,Rand J.S., Jonsson N.N.,Hughes I.P.,Morton J.M (2009). Frequency of fe- line diabetes mellitus and breed predisposition in domestic cats in Australia. Vet. J., 179: 254-258.]Search in Google Scholar
[Lee Y.S., Jun H.S. (2013). Anti-diabetic action of glucagon-like peptide-1 on pancreatic beta-cells. Metabolism, doi: 10.1016/j.metabol.2013.09.010.10.1016/j.metabol.2013.09.01024140094]Search in Google Scholar
[Link KR.Allio I.,Rand J.S.,Eppler E. (2013). The effect of experimentally induced chronic hyperglycaemia on serum and pancreatic insulin, pancreatic islet IGF-I and plasma and urinary ketones in the domestic cat (Felis felis). Gen. Comp. EndocrinoL. 188: 269-281.]Search in Google Scholar
[Lutz T.A., Rand J.S. (1995). Pathogenesis of feline diabetes mellitus. Vet. Clin. North. Am Small. Anim Pract., 25: 527-552.]Search in Google Scholar
[Maedler K, Spinas G.A., Lehmann R, Sergeev P., Weber M, Fontana A., Kai- ser N.. Donath M.Y. (2001). Glucose induced beta-cell apoptosis via upregulation of the Fas- receptor in human islets. Diabetes, 50: 1683-1690.]Search in Google Scholar
[Maedler K,Oberholzer J., Bur eher P., Spinas G.A., Donath MY. (2003). Monounsat- urated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes, 52: 726-733. ]Search in Google Scholar
[Maedler K, Sergeev P., Ehses JA., Mathe Z., Bosco D., Berney T.. Dayer J.M., R e i n e c k e M.. H a 1 b a n PA.. Donath M.Y. (2004). Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-lbeta in human islets. Proc. Natl. Acad. Sei. USA, 101: 8138-8143.]Search in Google Scholar
[McCann T.M., Simpson KE.. Shaw D.J., Butt JA., Gunn-Moore DA. (2007). Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire- based putative risk factor analysis. J. Feline Med. Surg.. 9: 289-299.]Search in Google Scholar
[Miller C., Bartges J., Cornelius L., Norton N., Barton M (1998). Tumor necrosis fac- tor-alpha levels in adipose tissue of lean and obese cats. J. Nutr.. 128: 2751S-2752S.]Search in Google Scholar
[Mori A, Lee P., Yamashita T., Nishimaki Y., Oda H., Saeki K, Miki Y., Mizu- tani R.Ishioka K.Honjo T.,Arai T.,Sako T. (2009). Effect of glimepiride and nateglin- ide on serum insulin and glucose concentration in healthy cats. Vet. Res. C'ommun., 33: 957-970.]Search in Google Scholar
[Nack R.. DeClue AE. (2014). In cats with newly diagnosted diabetes mellitus, use of a near-eu- glycemic management paradigm improves remission rate over a traditional paradigm Vet. Q.. 25: 1-5.]Search in Google Scholar
[Nelson RW., Feldman E.C.,Ford SI., Roe me r O.P (1993). Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats. J. Am Vet. Med. Assoc., 203: 821-827.]Search in Google Scholar
[Nelson R, Spann D.. Elliott D., Brondos A, Vulliet R (2004). Evaluation of the oral antihvperglycemic drug metformin in normal and diabetic cats. J. Vet. Intern. Med., 18: 18-24.]Search in Google Scholar
[Niessen S.J. (2010). Feline acromegaly: an essential differential diagnosis for the difficult diabetic. J. Feline Med. Surg., 12: 15-23.]Search in Google Scholar
[O'Brien T.D. (2002). Pathogenesis of feline diabetes mellitus. Mol. Cell. Endocrinol.. 197: 213-219.]Search in Google Scholar
[Os to M, Zini E., Reusch C.E., Lutz TA (2013). Diabetes from humans to cats. Gen. Comp. Endocrinol., 182: 48-53.]Search in Google Scholar
[Palus K. Rytel L., C a 1 k a J. (2013). Familial diseases in Chinese Shar-pei dogs associated with elevated levels of IL-6 (in Polish). Med. Weter., 69: 471-474.]Search in Google Scholar
[Perley M.J., Kipnis D.M. (1967). Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J. Clin. Invest., 46: 1954-1962.]Search in Google Scholar
[Porte D. (1991). Beta-cells in type II diabetes mellitus. Diabetes. 40: 166-180.]Search in Google Scholar
[Prahl Al., Guptill L.. G lie km an N.W., Tetrick M., Glickman L.T. (2007). Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals. J. Feline Med. Surg., 9: 351-358.]Search in Google Scholar
[Rand J.S. (1999). Current understanding of feline diabetes mellitus: part 1. pathogenesis. J. Feline Med. Surg., 1: 143-153.]Search in Google Scholar
[Rand J.S. (2013). Pathogenesis of feline diabetes. Vet. Clin. North. Am. Small. Anim Pract.. 43: 221-231.]Search in Google Scholar
[Rand J.S., Fleeman L.M. Farrow H.A., Appleton D.J., Lederer R (2004). Canine and feline diabetes mellitus: nature or nurture? J. Nutr., 134: 2072S-2080S.]Search in Google Scholar
[Reusch C.E., Padrutt I. (2013). New incretin hormonal therapies in humans relevant to diabetic cats. Vet. Clin. N. Am.-Small. 43: 417-433.]Search in Google Scholar
[Reusch C.E., Kley S.. Casella M, Nelson RW., Mol J., Zapf J. (2006). Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus. Vet. Rec.. 158: 195-200.]Search in Google Scholar
[Reusch C.E..Hafner M.,Tschuor F.,Lutz T.A.,Zini E. (2011). Diabetes remission in cats: a review. Schweiz. Arch. Tieiheilkd., 153: 495-500.]Search in Google Scholar
[Richardson V.R, Smith KA. Carter A.M. (2013). Adipose tissue inflammation: Feed- ing the development of type 2 diabetes mellitus. Immunobiology, <http://dx.doi.org/> 10.1016/j. imbio.2013.05.00210.1016/j.imbio.2013.05.00223816302]Search in Google Scholar
[Sallander M, Eli as son J., Hedhammar A. (2012). Prevalence and risk factors for the devel- opment of diabetes mellitus in Swedish cats. Acta Vet. Scand., 54, p. 61.10.1186/1751-0147-54-61353759723114390]Search in Google Scholar
[Slingerland L.L,Fazilova V.V.,Plantinga E.A.,Kooistra H.S..Beynen AC. (2009). Indoor confinement and physical inactivity rather than the proportion of dry food are risk factors in the development of feline type 2 diabetes mellitus. Vet. J., 179: 247-253. ]Search in Google Scholar
[Spellman C. W. (2010). Pathophysiology of type 2 diabetes: targeting islet cell dysfunction. J. Am. Osteopath. Assoc., 110: S2-7.]Search in Google Scholar
[Suzuki D., Toyoda M., Kimura M., Miyauchi M, Yamamoto N., Sato H.T Tana- ka E.. Kuriyama Y., Miyatake R. Abe M, Umezono T., Fukagavva M (2013). Effects of liraglutide. a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus. Intern Med., 52: 1029-1034.]Search in Google Scholar
[Trayhurn P.. Wood I.S. (2004). Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr., 92: 347-355.]Search in Google Scholar
[Wild S., Roglic G., Green A., Sicree R, King R (2004). Global prevalence of diabetes. Diabetes Care, 27: 1047-1053.]Search in Google Scholar
[Winzell M.S., Ahr e n B. (2007). G-protein-coupled receptors and islet function - implications for treatment of type 2 diabetes. Pharmacol. Ther., 116: 437-448.]Search in Google Scholar
[Zini E., Hafner M, Osto M., Franchini M, Ackermann M, Lutz T.A., Reusch C.E. (2010). Predictors of clinical remission in cats with diabetes mellitus. J. Vet. Intern Med.. 24: 1314-1321. ]Search in Google Scholar
